1. Home
  2. VVOS vs RANI Comparison

VVOS vs RANI Comparison

Compare VVOS & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • RANI
  • Stock Information
  • Founded
  • VVOS 2016
  • RANI 2012
  • Country
  • VVOS United States
  • RANI United States
  • Employees
  • VVOS N/A
  • RANI N/A
  • Industry
  • VVOS Medical Specialities
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • VVOS Health Care
  • RANI Health Care
  • Exchange
  • VVOS Nasdaq
  • RANI Nasdaq
  • Market Cap
  • VVOS 27.3M
  • RANI 24.2M
  • IPO Year
  • VVOS 2020
  • RANI 2021
  • Fundamental
  • Price
  • VVOS $2.89
  • RANI $0.47
  • Analyst Decision
  • VVOS Strong Buy
  • RANI Strong Buy
  • Analyst Count
  • VVOS 2
  • RANI 4
  • Target Price
  • VVOS $6.25
  • RANI $7.75
  • AVG Volume (30 Days)
  • VVOS 269.2K
  • RANI 317.0K
  • Earning Date
  • VVOS 11-13-2025
  • RANI 11-13-2025
  • Dividend Yield
  • VVOS N/A
  • RANI N/A
  • EPS Growth
  • VVOS N/A
  • RANI N/A
  • EPS
  • VVOS N/A
  • RANI N/A
  • Revenue
  • VVOS $14,393,000.00
  • RANI $1,200,000.00
  • Revenue This Year
  • VVOS $16.05
  • RANI N/A
  • Revenue Next Year
  • VVOS $43.75
  • RANI N/A
  • P/E Ratio
  • VVOS N/A
  • RANI N/A
  • Revenue Growth
  • VVOS 2.65
  • RANI N/A
  • 52 Week Low
  • VVOS $1.98
  • RANI $0.39
  • 52 Week High
  • VVOS $7.95
  • RANI $3.75
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 33.05
  • RANI 43.92
  • Support Level
  • VVOS $3.02
  • RANI $0.45
  • Resistance Level
  • VVOS $3.28
  • RANI $0.50
  • Average True Range (ATR)
  • VVOS 0.24
  • RANI 0.03
  • MACD
  • VVOS 0.02
  • RANI 0.00
  • Stochastic Oscillator
  • VVOS 9.84
  • RANI 30.59

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: